Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C43H67FN2O4S |
| Molecular Weight | 727.066 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 10 / 10 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(=C)[C@@H]1CC[C@@]2(CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC=C(C6=CC[C@](CF)(CC6)C(O)=O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12)NCCN7CCS(=O)(=O)CC7
InChI
InChIKey=YFSNREBZTKMFEB-DHGHKPCRSA-N
InChI=1S/C43H67FN2O4S/c1-29(2)31-12-19-43(45-22-23-46-24-26-51(49,50)27-25-46)21-20-40(6)33(36(31)43)8-9-35-39(5)15-13-32(38(3,4)34(39)14-16-41(35,40)7)30-10-17-42(28-44,18-11-30)37(47)48/h10,13,31,33-36,45H,1,8-9,11-12,14-28H2,2-7H3,(H,47,48)/t31-,33+,34-,35+,36+,39-,40+,41+,42+,43-/m0/s1
| Molecular Formula | C43H67FN2O4S |
| Molecular Weight | 727.066 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 10 / 10 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Tue Apr 01 22:47:11 GMT 2025
by
admin
on
Tue Apr 01 22:47:11 GMT 2025
|
| Record UNII |
M5FP5REG5Q
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
118435805
Created by
admin on Tue Apr 01 22:47:11 GMT 2025 , Edited by admin on Tue Apr 01 22:47:11 GMT 2025
|
PRIMARY | |||
|
1818867-24-1
Created by
admin on Tue Apr 01 22:47:11 GMT 2025 , Edited by admin on Tue Apr 01 22:47:11 GMT 2025
|
PRIMARY | |||
|
LM-07
Created by
admin on Tue Apr 01 22:47:11 GMT 2025 , Edited by admin on Tue Apr 01 22:47:11 GMT 2025
|
PRIMARY | |||
|
300000026312
Created by
admin on Tue Apr 01 22:47:11 GMT 2025 , Edited by admin on Tue Apr 01 22:47:11 GMT 2025
|
PRIMARY | |||
|
M5FP5REG5Q
Created by
admin on Tue Apr 01 22:47:11 GMT 2025 , Edited by admin on Tue Apr 01 22:47:11 GMT 2025
|
PRIMARY | |||
|
12083
Created by
admin on Tue Apr 01 22:47:11 GMT 2025 , Edited by admin on Tue Apr 01 22:47:11 GMT 2025
|
PRIMARY | |||
|
C188596
Created by
admin on Tue Apr 01 22:47:11 GMT 2025 , Edited by admin on Tue Apr 01 22:47:11 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET ORGANISM->INHIBITOR |
HIV maturation inhibitor: Exhibited robust antiviral activity against a panel of HIV-1 clinical isolates, with a mean EC50 of 9?nM
EC50
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
|
EXCRETED UNCHANGED |
Accounting for 44% of total
radioactivity
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
TARGET -> INHIBITOR |
INHIBITS THE CONVERSION OF P25 TO P24
|
||
|
|
CUMULATIVE EXCRETION |
FECAL
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
METABOLITE -> PARENT |
Forms in bile in high amounts may be recirculated back into plasma.
|
||
|
METABOLITE -> PARENT |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| Volume of Distribution | PHARMACOKINETIC |
|
|
|||
| Biological Half-life | PHARMACOKINETIC |
|
|
|||